scholarly journals Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies

2008 ◽  
Vol 149 (7) ◽  
pp. 461 ◽  
2009 ◽  
Vol 53 (8) ◽  
pp. 969-975 ◽  
Author(s):  
Giovanna A. Balarini Lima ◽  
Lívia L. Corrêa ◽  
Rafael Gabrich ◽  
Luiz Carlos D. de Miranda ◽  
Mônica R. Gadelha

Prostate cancer is the second most frequent malignancy diagnosed in adult men. Androgens are considered the primary growth factors for prostate normal and cancer cells. However, other non-androgenic growth factors are involved in the growth regulation of prostate cancer cells. The association between IGF-I and prostate cancer risk is well established. However, there is no evidence that the measurement of IGF-I enhances the specificity of prostate cancer detection beyond that achievable by serum prostate-specific antigen (PSA) levels. Until now, there is no consensus on the possible association between IGFBP-3 and prostate cancer risk. Although not well established, it seems that high insulin levels are particularly associated with risk of aggressive prostatic tumours. This review describes the physiopathological basis, epidemiological evidence, and animal models that support the association of the IGFs family and insulin with prostate cancer. It also describes the potential therapies targeting these growth factors that, in the future, can be used to treat patients with prostate cancer.


Author(s):  
Francesca L. Crowe ◽  
Paul N. Appleby ◽  
Ruth C. Travis ◽  
Matt Barnett ◽  
Theodore M. Brasky ◽  
...  

2018 ◽  
Vol 79 (1) ◽  
pp. 274-285 ◽  
Author(s):  
Ruth C. Travis ◽  
Aurora Perez-Cornago ◽  
Paul N. Appleby ◽  
Demetrius Albanes ◽  
Corinne E. Joshu ◽  
...  

2018 ◽  
Vol 74 (5) ◽  
pp. 585-594 ◽  
Author(s):  
Eleanor L. Watts ◽  
Paul N. Appleby ◽  
Aurora Perez-Cornago ◽  
H. Bas Bueno-de-Mesquita ◽  
June M. Chan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document